Alivus Life Sciences to Host Q1 FY2026-27 Earnings Call on July 31
Alivus Life Sciences has scheduled a Q1 FY2026-27 earnings call for July 31, 2026, from 8:30 AM to 9:30 AM IST. The call will be accessible to participants in India via universal dial-in numbers, as well as to international attendees through toll-free and toll numbers across regions including Australia, Canada, China, Hong Kong, Japan, Singapore, the UK, and the USA. Stakeholders can pre-register online and direct queries to designated company contacts.
*this image is generated using AI for illustrative purposes only.
Alivus Life Sciences Ltd will conduct an earnings call to discuss its financial performance for the first quarter of FY2026-27. The conference is scheduled for Friday, July 31, 2026, from 8:30 AM to 9:30 AM IST. This session allows investors and analysts to review the company's quarterly results and operational outlook directly with management.
The company has provided universal dial-in numbers for participants within India. International attendees can access the call via designated toll-free numbers for regions including Australia, Canada, China, Hong Kong, Italy, Japan, Singapore, South Korea, the UK, and the USA. Toll numbers are also available for Hong Kong, Japan, Singapore, South Africa, the UK, and the USA.
Dial-in Details
Universal Dial-in Numbers
| Number: | Details |
|---|---|
| Dial-in 1: | +91 22 6280 1564 |
| Dial-in 2: | +91 22 7115 8394 |
International Toll-Free Access
| Country: | Number |
|---|---|
| Australia: | 1800053698 |
| Canada: | 01180014243444 |
| China: | 4008428405 |
| Hong Kong: | 800964448 |
| Italy: | 0080014243444 |
| Japan: | 00531161110 |
| Singapore: | 8001012045 |
| South Korea: | 00180014243444 |
| UK: | 08081011573 |
| USA: | 18667462133 |
International Toll Access
| Country: | Number |
|---|---|
| Hong Kong: | +852 30186877 |
| Japan: | +81 345899421 |
| Singapore: | +65 31575746 |
| South Africa: | +27 110623033 |
| UK: | +44 2034785524 |
| USA: | +1 3233868721 |
Participants can pre-register online for the event. For further clarification regarding the earnings call, stakeholders may contact Diwakar Pingle or Runjhun Jain via email.
Historical Stock Returns for Alivus Life Sciences
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -2.34% | +1.89% | +17.33% | +46.44% | +46.75% | +81.95% |
How is Alivus Life Sciences expected to adjust its FY2026-27 full-year revenue guidance following the Q1 performance?
What specific operational challenges or regulatory hurdles might impact the company's pipeline progression in the upcoming quarters?
Will management address any changes in raw material costs or supply chain dynamics affecting gross margins for the rest of the fiscal year?
18
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
